What's breaking now, across thousands of outlets.
The deal gives AstraZeneca a simpler way to make conjugate vaccines. Elsewhere, a psychedelic depression drug was submitted to the FDA and an autoimmune disease-focused biotech’s shares collapsed.
We haven't written up this one. BioPharma Dive has the full story — the link below goes straight to it.
New research led by QIMR Berghofer has uncovered a decades-long increase in the rates of a common form of skin cancer across Australia and Europe, highlighting a growing but underrecognized public…
KOTA KINABALU: Sabah has successfully performed its second separation surgery on conjoined twins, bringing forward the operation after one of the babies required increasing respiratory support.
(MedPage Today) -- ORLANDO -- A large head-to-head trial reported here that pitted bimekizumab (Bimzelx) against risankizumab (Skyrizi) as treatment for psoriatic arthritis (PsA) yielded a winner…
Now that the UK government has increased its spending on medicines, it’s calling for life sciences companies to do their part and invest on home soil. “We are determined to ensure that the UK is ...
Beeline Medicines fleshed out an impressive mid-stage win in systemic lupus on Wednesday, setting the stage for Phase 3 trials with a former drug from Bristol Myers Squibb.
While young people are drinking less across the board, one expert says a small minority are actually drinking huge and damaging amounts of alcohol Get our breaking news email , free app or daily news…
